文献速递主动脉疾病

主动脉夹层入院后再次入院的影响因素与手术方式分析

Impact of patient factors and procedure on readmission after aortic dissection admission in the states of Florida and New York.
PubMed 文献 · J Vasc Surg · 2020-04-01

基于佛罗里达州和纽约州行政索赔数据,纳入4670例主动脉夹层指数入院患者,分析不同初始治疗策略(TAOR、TBOR、TEVAR、MM)的再入院率及相关因素。结果显示30天、90天和2年再入院率在各治疗组间无显著差异,2年再入院常见,社会经济、种族和地理因素可能与再入院模式相关。

要点

  • 主动脉夹层后30天再入院率9.6%-11%,90天15.2%-20%,2年49.2%-54.4%,各治疗组无显著差异。
  • 2年时自费(vs Medicare)与再入院 odds 降低相关,合并症多和黑人种族与再入院 odds 升高相关。
  • 心血管疾病是所有时间点最常见的再入院原因。

核心结论

  • 主动脉夹层指数入院后30天、90天和2年再入院率与初始治疗类型无关。
  • 2年再入院常见,针对社会经济、种族和地理因素的措施可能减少再入院模式差异。

研究设计与样本

  • 基于佛罗里达州(2007-2012)和纽约州(2008-2012)州住院患者数据库的回顾性队列研究,纳入4670例主动脉夹层指数入院患者。
  • 按初始治疗策略分层:TAOR 1031例(22%)、TBOR 761例(16%)、TEVAR 412例(9%)、MM 2466例(53%)。
  • 患者以男性(59.4%)和白人(61.9%)为主,中位年龄66岁。

主要发现

  • 指数入院总体死亡率为14.8%(TAOR 15.8%,TBOR 17.1%,TEVAR 9.0%,MM 14.7%;P = .002)。
  • 30天再入院率9.6%-11%(P = .56),90天15.2%-20%(P = .26),2年49.2%-54.4%(P = .15),各治疗组间相似。
  • 较高收入四分位(vs 最低)与B型夹层入院后早期(30天和90天)再入院 odds 降低相关,A型中无此关联。
  • 2年时自费(vs Medicare)与A型和B型入院再入院 odds 降低相关,合并症数量多和黑人种族(vs 白人)与再入院 odds 升高相关。
  • TEVAR(vs MM)与再入院 odds 升高相关;心血管疾病是所有时间点最常见再入院原因。

关键数值与推荐

  • 30天再入院率9.6%-11%(P = .56),90天15.2%-20%(P = .26),2年49.2%-54.4%(P = .15)。
  • 指数入院死亡率14.8%(TAOR 15.8%,TBOR 17.1%,TEVAR 9.0%,MM 14.7%;P = .002)。

临床怎么用

  • 主动脉夹层后2年再入院常见,需关注长期随访和管理。
  • 针对社会经济、种族和地理因素制定策略可能减少再入院差异。

局限性

  • 基于行政索赔数据,可能存在编码不准确和未调整混杂因素。
  • 仅纳入佛罗里达州和纽约州数据,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Readmissions after aortic dissection (AD) admission are not well described. Using state-based administrative claims data, we sought to define readmission rates after AD and to identify factors associated with them. METHODS: State Inpatient Databases for Florida (2007-2012) and New York (2008-2012) were queried for AD index admissions. Admissions were stratified by initial treatment strategy: type A open surgery repair (TAOR), type B open surgery repair (TBOR), thoracic endovascular aortic repair (TEVAR), or medical management (MM). All-cause readmission rates were calculated at 30 days, 90 days, and 2 years. Logistic regression was used to identify factors associated with readmission at each time point for all type A admissions (TAOR) or type B admissions (TBOR, TEVAR, MM). RESULTS: We identified 4670 patients with an AD index admission. Treatment was with TAOR in 1031 (22%), TBOR in 761 (16%), TEVAR in 412 (9%), and MM in 2466 (53%). Patients were predominantly male (59.4%) and white (61.9%), with a median age of 66 years. Overall mortality during AD index admission was 14.8% (TAOR, 15.8%; TBOR, 17.1%; TEVAR, 9.0%; MM, 14.7%; P = .002 across all groups). All-cause readmission rates were similar across treatment groups at 30 days (9.6%-11%; P = .56), 90 days (15.2%-20%; P = .26), and 2 years (49.2%-54.4%; P = .15). Higher income quartile (vs lowest) was associated with lower odds of early readmission (at 30 days and 90 days) after type B admissions but not after type A admissions. At 2 years, self-pay (vs Medicare) was associated with lower odds of readmission in both type A and type B admissions, whereas higher comorbidity count and black race (vs white) were associated with higher odds of readmission. TEVAR (vs MM) was also associated with higher odds of readmission. Cardiovascular disease was the most common cause for readmission at all time points. Emergency department readmission counts were highest after MM admissions, and ambulatory surgical admissions were highest after TBOR. Both TEVAR and MM initial costs were lower than TAOR and TBOR costs, but at 2 years, costs remained significantly lower only for MM. CONCLUSIONS: In-state 30-day, 90-day, and 2-year readmission rates after AD were not associated with initial treatment type. Two-year readmissions are common. Strategies to target socioeconomic, race, and geographic factors may reduce variations in readmission patterns after AD admission.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Weiss S, Rojas RL, Habermann EB, et al. Impact of patient factors and procedure on readmission after aortic dissection admission in the states of Florida and New York. J Vasc Surg. 2020. PMID: 32247702. doi:10.1016/j.jvs.2020.01.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。